PL360699A1 - Process for making n-aryl-anthranilic acids and their derivatives - Google Patents

Process for making n-aryl-anthranilic acids and their derivatives

Info

Publication number
PL360699A1
PL360699A1 PL36069901A PL36069901A PL360699A1 PL 360699 A1 PL360699 A1 PL 360699A1 PL 36069901 A PL36069901 A PL 36069901A PL 36069901 A PL36069901 A PL 36069901A PL 360699 A1 PL360699 A1 PL 360699A1
Authority
PL
Poland
Prior art keywords
aryl
derivatives
making
anthranilic acids
anthranilic
Prior art date
Application number
PL36069901A
Other languages
English (en)
Polish (pl)
Inventor
Michael Huai Gu Chen
Edward Mark Davis
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner-Lambert Company Llc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc. filed Critical Warner-Lambert Company Llc.
Publication of PL360699A1 publication Critical patent/PL360699A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
PL36069901A 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives PL360699A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25
PCT/US2001/022948 WO2002018319A1 (en) 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives

Publications (1)

Publication Number Publication Date
PL360699A1 true PL360699A1 (en) 2004-09-20

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36069901A PL360699A1 (en) 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives

Country Status (32)

Country Link
EP (1) EP1313694A1 (bg)
JP (1) JP2004507518A (bg)
KR (1) KR20030059115A (bg)
CN (1) CN1458921A (bg)
AP (1) AP2001002249A0 (bg)
AR (1) AR032175A1 (bg)
AU (1) AU2001277044A1 (bg)
BG (1) BG107635A (bg)
BR (1) BR0113520A (bg)
CA (1) CA2420003A1 (bg)
CZ (1) CZ2003477A3 (bg)
DO (1) DOP2001000238A (bg)
EA (1) EA200300187A1 (bg)
GT (1) GT200100174A (bg)
HN (1) HN2001000216A (bg)
HU (1) HUP0300828A2 (bg)
IL (1) IL154507A0 (bg)
IS (1) IS6724A (bg)
MA (1) MA26949A1 (bg)
MX (1) MXPA03001654A (bg)
NO (1) NO20030844L (bg)
PA (1) PA8526501A1 (bg)
PE (1) PE20020393A1 (bg)
PL (1) PL360699A1 (bg)
PY (1) PY0120841A (bg)
SK (1) SK2072003A3 (bg)
SV (1) SV2002000601A (bg)
TN (1) TNSN01127A1 (bg)
UY (1) UY26908A1 (bg)
WO (1) WO2002018319A1 (bg)
YU (1) YU14303A (bg)
ZA (1) ZA200301182B (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG2013013339A (en) 2002-03-13 2014-12-30 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
WO2005040098A1 (en) 2003-10-21 2005-05-06 Warner-Lambert Company Llc Polymorphic form of n-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
CA2546353A1 (en) 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
CA2546754A1 (en) 2003-11-21 2005-06-09 Array Biopharma Inc. Akt protein kinase inhibitors
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
KR101411167B1 (ko) 2005-04-13 2014-06-23 아스텍스 테라퓨틱스 리미티드 하이드록시벤즈아미드 유도체 및 hsp90 억제제로서의이의 용도
SG177981A1 (en) 2005-05-18 2012-02-28 Array Biopharma Inc 4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
EP2049500B1 (en) 2006-07-06 2011-09-07 Array Biopharma, Inc. Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
ATE532789T1 (de) 2006-07-06 2011-11-15 Array Biopharma Inc Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
US8329701B2 (en) 2006-07-06 2012-12-11 Array Biopharma Inc. Dihydrofuro pyrimidines as AKT protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
CN103396409B (zh) 2007-07-05 2015-03-11 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
CN101918373B (zh) 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8853216B2 (en) 2008-01-09 2014-10-07 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
NZ586346A (en) 2008-01-09 2012-02-24 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
CN102958892A (zh) * 2010-02-19 2013-03-06 国家科学研究中心 通过芳香族亲核取代来制备目的化合物的方法
CA2789373A1 (en) * 2010-02-19 2011-08-25 Centre National De La Recherche Scientifique Process for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group
KR102021157B1 (ko) 2011-04-01 2019-09-11 제넨테크, 인크. Akt 억제제 화합물 및 아비라테론의 조합물, 및 사용 방법
TR201815685T4 (tr) 2011-04-01 2018-11-21 Genentech Inc Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
MA38085B1 (fr) * 2012-10-12 2018-11-30 Exelixis Inc Nouveau procédé pour la production de composés à utiliser dans le traitement du cancer
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
WO1998037881A1 (en) * 1997-02-28 1998-09-03 Warner Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
NZ501276A (en) * 1997-07-01 2000-10-27 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
CA2290509A1 (en) * 1997-07-01 1999-01-14 Warner-Lambert Company 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
DE60017109T2 (de) * 1999-04-21 2006-01-12 Warner-Lambert Co. Llc Verfahren zur herstellung von 2-(n-phenylalmino)benzoesäure

Also Published As

Publication number Publication date
UY26908A1 (es) 2001-11-30
KR20030059115A (ko) 2003-07-07
PA8526501A1 (es) 2002-07-30
EA200300187A1 (ru) 2003-08-28
GT200100174A (es) 2002-07-18
NO20030844L (no) 2003-02-25
WO2002018319A1 (en) 2002-03-07
AU2001277044A1 (en) 2002-03-13
BG107635A (bg) 2004-09-30
JP2004507518A (ja) 2004-03-11
YU14303A (sh) 2006-08-17
AP2001002249A0 (en) 2001-09-30
PE20020393A1 (es) 2002-05-09
PY0120841A (es) 2004-06-01
IS6724A (is) 2003-02-20
HN2001000216A (es) 2002-05-22
AR032175A1 (es) 2003-10-29
HUP0300828A2 (hu) 2003-09-29
ZA200301182B (en) 2004-05-12
SV2002000601A (es) 2002-04-03
NO20030844D0 (no) 2003-02-24
EP1313694A1 (en) 2003-05-28
DOP2001000238A (es) 2003-01-31
MXPA03001654A (es) 2004-09-10
TNSN01127A1 (en) 2005-11-10
MA26949A1 (fr) 2004-12-20
CN1458921A (zh) 2003-11-26
CZ2003477A3 (cs) 2003-10-15
SK2072003A3 (en) 2004-01-08
CA2420003A1 (en) 2002-03-07
IL154507A0 (en) 2003-09-17
BR0113520A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
IL154507A0 (en) Process for making n-aryl-anthranilic acids and their derivatives
CZ20023563A3 (cs) Způsob přípravy 2-halogenbenzoových kyselin
HUP0203875A3 (en) Microcapsule and process for production thereof
GB0011120D0 (en) Process
AU2001264134A1 (en) Microconnectors and method for their production
AU1497802A (en) Ss-thio-amino acids
GB0010437D0 (en) Process
GB0002201D0 (en) Process
IL133121A0 (en) Process for making 2-alkyl-3-hydroxybenzoic acids
HUP9902559D0 (en) Pharmaceutical composition and process for producing it
HUP0303579A3 (en) Process for preparing lipid ii and derivatives thereof
GB0014580D0 (en) Appatarus and process
EP1310503A4 (en) PROCESS FOR THE PRODUCTION OF HYDRAZINOMONOSACCHARIDE DERIVATIVES AND THEIR USE
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
IL151451A0 (en) Process for producing quinolonecarboxylic acids and intermediates thereof
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones
IL129330A (en) Phenoxy-phenylsulfonic acid derivatives and process for their preparation
HUP0301141A3 (en) Method for the production of trioxime derivatives
AU2002211034A1 (en) Aziridinylquinolinedione derivatives and process for their preparation
GB0108012D0 (en) Fixed bed sweeting process
GB0001564D0 (en) Process
HUP0204270A3 (en) Process for preparing cyclohexancarbonitrile derivatives and their intermediates
SI1175428T1 (en) 3-deoxy-desmycosin derivatives and process for their preparation
HUP0301741A3 (en) Method for producing 4-bromine-aniline derivatives